Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News ...

Scientists have identified the Plvap gene as a key regulator of metabolism during fasting. Disabling it in mice prevented the ...

Eli Lilly (NYSE: LLY) stock has had plenty of good trading sessions over the past year or so, but Monday's sure wasn't among ...

Eli Lilly is set to launch its popular weight-loss drug in emerging markets, including India, Brazil, and Mexico, by mid-2025 ...

Budget hearings are over at the State Capitol, but one particular expense involving a popular weight loss drug has caught the ...

"My doctor labelled me as 'overweight' and borderline 'obese.' The doctor barely looked at me before making that assessment," ...

As a certified nutrition coach and clinical weight-loss practitioner, I believe the best diets for weight loss are those that ...

CagriSema is a fixed-dose combination of cagrilintide, a long-acting amylin analogue, and semaglutide, a glucagon-like peptide-1 receptor agonist.

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

It seems like no matter what I do, I can't lose weight. Most of my family members struggle with their weight too. Do our ...

Novo Nordisk stock tumbled Monday morning after disappointing trial results for its CagriSema weight-loss drug. Shares in ...

It's not too often that pharmaceutical drugs become household names, but that's happening with medicines in the weight loss market. Brands such as Wegovy and Zepbound -- the leading anti-obesity ...